The addition of haloperidol, propofol, or midazolam to sufentanil for intravenous sedation in the intensive care unit using bispectral index

Basit Öğe Kaydı
dc.authorscopusid6506306004
dc.authorscopusid7003369853
dc.authorscopusid6701467427
dc.contributor.authorTukenmez B.
dc.contributor.authorMemis D.
dc.contributor.authorPamukcu Z.
dc.date.accessioned2024-06-12T10:26:25Z
dc.date.available2024-06-12T10:26:25Z
dc.date.issued2008
dc.description.abstractAim: Inadequate sedative techniques may adversely affect morbidity and mortality in the intensive care unit (ICU), and the search for the ideal sedative agent continues. Combinations of hypnotics and opiates have are commonly used for sedation. In this study, the authors aimed to assess whether or not the addition of a haloperidol, propofol, or midazolam infusion decreased the sufentanil requirements by using bispectral index (BIS). Material and Methods: The study involved 60 patients in the ICU. All patients received 0.5 ?g/kg sufentanil IV bolus. Immediately after, group S received 0.25 ?g/kg sufentanil infusion, group SH received sufentanil infusion + haloperidol 3 mg/h infusion, group SP received sufentanil infusion + propofol 25 ?g/kg/min infusion, and group SM received sufentanil infusion + midazolam 0.04 mg/kg/h infusion, for 6 hours. Average BIS values 61-80 and Ramsay Sedation Score 2-5 were kept at a range of by decreasing or increasing sufentanil levels in all groups and hourly sufentanil consumption was determined. Hemodynamic and biochemical parameters and arterial blood gases were determined at baseline and were repeated in study hours. Results: There was no significant difference in hemodynamic and biochemical parameters and arterial blood gases among the groups. Propofol, midazolam, haloperidol infusion, when added to sufentanil infusion, decreased the consumption of sufentanil in all the measured times (p < 0.001). Conclusions: The authors aimed to determine the effects of haloperidol, propofol, or midazolam infusion when added to sufentanil infusion in a short period of time. The authors found that propofol, midazolam, and haloperidol infusion decreased the sufentanil requirements in ICU patients.en_US
dc.identifier.doi10.5055/jom.2008.0006
dc.identifier.endpage40en_US
dc.identifier.issn1551-7489
dc.identifier.issue1en_US
dc.identifier.pmid18444446en_US
dc.identifier.scopus2-s2.0-41549106656en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage34en_US
dc.identifier.urihttps://doi.org/10.5055/jom.2008.0006
dc.identifier.urihttps://hdl.handle.net/20.500.14551/16837
dc.identifier.volume4en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWeston Medical Publishingen_US
dc.relation.ispartofJournal of Opioid Managementen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBispectral Index; Haloperidol; Intensive Care Unit; Midazolam; Propofol; Sedation; Sufentanilen_US
dc.subjectHaloperidol; Midazolam; Midazolam Maleate; Norodol; Placebo; Propofol; Sufentanil; Unclassified Drug; Absence Of Side Effects; Adult; Aged; Anesthesiological Techniques; Arterial Gas; Article; Bispectral Index; Bolus Injection; Chemical Analysis; Clinical Trial; Continuous Infusion; Controlled Clinical Trial; Controlled Study; Double Blind Procedure; Drug Response; Drug Safety; Drug Use; Female; Hemodynamic Parameters; Human; Intensive Care Unit; Major Clinical Study; Male; Randomized Controlled Trial; Scoring System; Sedationen_US
dc.titleThe addition of haloperidol, propofol, or midazolam to sufentanil for intravenous sedation in the intensive care unit using bispectral indexen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu